openPR Logo
Press release

Tapentadol Market to Undertake Strapping Growth During 2017 - 2025

12-22-2017 01:51 PM CET | Business, Economy, Finances, Banking & Insurance

Press release from: Persistence Market Research

/ PR Agency: Persistence Market Research
Tapentadol Market to Undertake Strapping Growth During 2017 -

Tapentadol is an analgesic with a dual mode of action as a norepinephrine reuptake inhibitor and an agonist of the mu-opioid receptor. Its analgesic properties come into effect within few minutes of oral administration. Tapentadol is a new drug, being approved by the U.S. Food and Drug Administration (FDA) on the twenty sixth of August 2011, by the Therapeutic Goods Administration (TGA) of Australia on the twenty fourth of December 2010 and by the Medicines and Healthcare products Regulatory Agency (MHRA) of the UK on the fourth of February 2011. Tapentadol has been recognized as a step three analgesic on the World Health Organization (WHO) pain ladder. Tapentadol is utilized for the treatment of moderate to severe pain for chronic and acute musculoskeletal pain. Tapentadol is available in the U.S. in extended release formulations as Nucynta ER from Janssen Pharmaceuticals. Nucynta contains the (R,R) stereoisomer, which is a weak isomer in terms of opioid activity.

Request Report for TOC @ https://www.persistencemarketresearch.com/toc/20656

Tapentadol is often used to ease pain which cannot be managed with other types of analgesics. Tapentadol formulation is provided in 100 mg (red/orange), 75 mg (orange) and 50 mg (yellow) tablets to be used once every five hours as needed to control pain. In addition, tapentadol can be used for controlling the pain of diabetic neuropathy when round the clock analgesic is required. Furthermore, tapentadol can be used to treat chronic depression, although it is not approved for this treatment. However, tapentadol is known to have adverse side effects. Tapentadol may impair cognitive and physical abilities and should not be used when operating heavy machinery, especially during initial treatment. Dizziness, nausea, constipation and central nervous system (CNS) sedation are common side effects of tapentadol. Tapentadol can increase the risk of seizure and should be administered carefully to epileptic patients.

The growth in the analgesic market is expected to increase the consumption of tapentadol. In addition, rising demand for over the counter painkillers in emerging economies of Asia Pacific is expected to boost demand for tapentadol. However, government regulations, availability of substitutes and adverse effects of tapentadol could hamper the growth of the market.

Request to Sample of Report @ https://www.persistencemarketresearch.com/samples/20656

North America is the largest market for tapentadol followed by Europe and Asia Pacific. The U.S is the largest country market in North America followed by Canada. Ageing population represents the key growth driver for the US market. Growth-wise, Asia-Pacific is projected to be the fastest growing market for tapentadol. China and India are expected to be the largest consumers of tapentadol in Asia Pacific due to growing population and rapid urbanization. Taiwan, Honk Kong, Japan, Republic of Korea, Malaysia and Indonesia are other major consumers of tapentadol in Asia Pacific. Increasing consumer awareness, better treatment and an increase in life expectancy is likely to propel future growth.

Pre Book Full Report @ https://www.persistencemarketresearch.com/checkout/20656

The market is dominated by large pharmaceutical companies with established brands. Some of the key players operating in this market are Johnson & Johnson Pharmaceutical Research & Development, L.L.C (U.S.), IPCA Laboratories Ltd (India), Lupin Laboratories Ltd (India), Ranbaxy Laboratories Ltd.(India), Aristo Pharmaceuticals Pvt Ltd (India), Cadila Pharmaceuticals Ltd (India), Tirupati Medicare Ltd (India) and Manus Aktteva Biopharma LLP (India) among others. Companies are investing in research and development to develop new grades of Tapentadol. In addition, companies are using strategic acquisitions and mergers to remain competitive in market and increasing their presence in emerging economies of Asia Pacific and Latin America.

About Us

Persistence Market Research (PMR) is a third-platform research firm. Our research model is a unique collaboration of data analytics and market research methodology to help businesses achieve optimal performance.

To support companies in overcoming complex business challenges, we follow a multi-disciplinary approach. At PMR, we unite various data streams from multi-dimensional sources. By deploying real-time data collection, big data, and customer experience analytics, we deliver business intelligence for organizations of all sizes.

Contact Us

Persistence Market Research
305 Broadway
7th Floor, New York City,
NY 10007, United States,
USA Canada Toll Free: 800-961-0353
Email: sales@persistencemarketresearch.com
Web: http://www.persistencemarketresearch.com

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Tapentadol Market to Undertake Strapping Growth During 2017 - 2025 here

News-ID: 873639 • Views:

More Releases from Persistence Market Research

Korea Heavy-duty Corrugated Packaging Market to Reach US$1.6 Billion by 2033 - Persistence Market Research
Korea Heavy-duty Corrugated Packaging Market to Reach US$1.6 Billion by 2033 - P …
The Korea heavy-duty corrugated packaging market plays a critical role in supporting industrial logistics, bulk transportation, and export-driven manufacturing. Heavy-duty corrugated packaging is widely used for shipping machinery, automotive components, electronics, chemicals, and large industrial goods that require superior strength and structural integrity. Unlike conventional corrugated boxes, heavy-duty variants are engineered with multi-wall boards, reinforced liners, and customized structural designs to withstand high load capacity, stacking pressure, and long-distance transportation.
Textile Flooring Market Set for Steady Growth as Demand for Sustainable and Stylish Interiors Rises
Textile Flooring Market Set for Steady Growth as Demand for Sustainable and Styl …
The global textile flooring market is entering a phase of stable expansion, supported by rising construction activity, increasing consumer focus on interior aesthetics, and growing demand for eco-friendly flooring solutions. According to industry estimates, the global textile flooring market size is likely to be valued at US$11.1 billion in 2026 and is projected to reach US$16.5 billion by 2033, expanding at a CAGR of 5.8% between 2026 and 2033. This
Power System Simulator Market Size to Reach US$ 2.6 Billion by 2033 - Persistence Market Research
Power System Simulator Market Size to Reach US$ 2.6 Billion by 2033 - Persistenc …
The power system simulator market is gaining strategic importance as global energy systems transition toward digitalization, decentralization, and decarbonization. Power system simulators are advanced software and hardware platforms used by utilities, grid operators, engineering firms, and research institutions to model, analyze, and optimize electrical power networks. These simulators enable real time grid analysis, contingency planning, load flow studies, fault analysis, stability assessment, and operator training. As electricity networks become more
Yoga and Meditation Products Market Set for Robust Growth, Projected to Reach US$ 15.5 Billion by 2033
Yoga and Meditation Products Market Set for Robust Growth, Projected to Reach US …
The global wellness industry is undergoing a major transformation as consumers increasingly prioritize mental health, mindfulness, and preventive self-care. Within this evolving landscape, the yoga and meditation products market has emerged as a fast-growing segment, encompassing everything from yoga mats and apparel to meditation cushions, smart devices, and digital-enabled accessories. According to industry estimates, the global yoga meditation products market is projected to be valued at US$ 8.3 billion in

All 5 Releases


More Releases for Tapentadol

Tapentadol Market to Witness Huge Growth by 2031 - Johnson & Johnson Services, I …
DataM Intelligence has published a new research report on "Tapentadol Market Size 2024". The report explores comprehensive and insightful Information about various key factors like Regional Growth, Segmentation, CAGR, Business Revenue Status of Top Key Players and Drivers. The purpose of this report is to provide a telescopic view of the current market size by value and volume, opportunities, and development status. Get a Free Sample Research PDF - https://datamintelligence.com/download-sample/tapentadol-market The
The Tapentadol Market to witness an innovative overhaul between 2017 - 2025
Tapentadol Market Tapentadol is an analgesic with a dual mode of action as a norepinephrine reuptake inhibitor and an agonist of the mu-opioid receptor. Its analgesic properties come into effect within few minutes of oral administration. Tapentadol is a new drug, being approved by the U.S. Food and Drug Administration (FDA) on the twenty sixth of August 2011, by the Therapeutic Goods Administration (TGA) of Australia on the twenty fourth of
The next 10 years to see the Tapentadol Market making green strides
Tapentadol Market Tapentadol is an analgesic with a dual mode of action as a norepinephrine reuptake inhibitor and an agonist of the mu-opioid receptor. Its analgesic properties come into effect within few minutes of oral administration. Tapentadol is a new drug, being approved by the U.S. Food and Drug Administration (FDA) on the twenty sixth of August 2011, by the Therapeutic Goods Administration (TGA) of Australia on the twenty fourth of
Tapentadol Market Grows With Changing Consumer Preferences & New Opportunities
Market: Overview Tapentadol is an analgesic with a dual mode of action as a norepinephrine reuptake inhibitor and an agonist of the mu-opioid receptor. Its analgesic properties come into effect within few minutes of oral administration. Tapentadol is a new drug, being approved by the U.S. Food and Drug Administration (FDA) on the twenty sixth of August 2011, by the Therapeutic Goods Administration (TGA) of Australia on the twenty fourth of
Tapentadol Market High Growth Rate by 2025
Global Tapentadol Market: Snapshot The growing prevalence of chronic diseases is leading to the high occurrence of chronic musculoskeletal pain, which is likely to create an upswing in the demand for tapentadol worldwide. Tapentadol is also used for the treatment of moderate to severe acute pain. The potency of this treatment lies somewhere between that of morphine and tramadol. Despite the lower occurrence of side effects, its analgesic efficacy is
Middle East Tapentadol Market Forecast to 2025
Tapentadol is an opioid analgesic, indicated for severe pain management, on a daily or around the clock need for treatment and long-term opioid treatment, for which alternative treatment options are inadequate. Tapentadol is also indicated for neuropathic pain associated with diabetic peripheral neuropathy. It is widely used for management of acute, chronic, and cancer related pain among patients and is available legally on prescription. Nucynta ER is the first and